Sign In
Buy PRNB
$100.05
+0 (+0%)
At Close: May 27, 2022
Principia to Present at 9th Annual SVB Leerink Global Healthcare Conference
01:01pm, Wednesday, 19'th Feb 2020
SOUTH SAN FRANCISCO, Calif., Feb. 19, 2020 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Nasdaq: PRNB), a late-stage biopharmaceutical company focused on...
Could This Cancer Drug Developer’s Stock Make You Rich?
03:15pm, Friday, 14'th Feb 2020
Investing in this emerging cancer-focused biotech may just allow you to retire early.
Principia Biopharma: Hype Over Multiple Sclerosis "Data" Is Overblown
04:00pm, Wednesday, 12'th Feb 2020
Patient improvement during Phase 2 trial of Principia's drug likely caused not by the drug but by regression to the mean. We believe secondary-endpoint results
Principia Biopharma (PRNB) Receives a Buy from Stifel Nicolaus
08:00am, Monday, 10'th Feb 2020
In a report issued on February 6, Derek Archila from Stifel Nicolaus reiterated a Buy rating on Principia Biopharma (PRNB
Principia Biopharma (NASDAQ:PRNB) Price Target Raised to
03:54pm, Sunday, 09'th Feb 2020
Principia Biopharma (NASDAQ:PRNB) had its price objective lifted by HC Wainwright from to in a report released on Thursday, The Fly reports. They currently have a buy rating on the stock. A number of
Principia Biopharma (NASDAQ:PRNB) Upgraded at BidaskClub
02:07pm, Sunday, 09'th Feb 2020
BidaskClub upgraded shares of Principia Biopharma (NASDAQ:PRNB) from a buy rating to a strong-buy rating in a research note published on Thursday morning, BidAskClub reports. A number of other analyst
The Daily Biotech Pulse: Assertio To Sell Opioid Pain Drug, Milestone Payment For Aduro, Myriad Genetics CEO Resigns
12:32pm, Friday, 07'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 6) Acceleron Pharma Inc (NASDAQ: XLRN ) Alector Inc (N
Principia Biopharma (PRNB) Gets a Buy Rating from Wells Fargo
03:25am, Friday, 07'th Feb 2020
In a report released yesterday,
Jim Birchenough
from Wells Fargo maintained a
Buy
rating on Principia Biopharma (
PRNB
–
Research Report
). The company’s shares closed last Monday at $69.01, close
Principia Biopharma (PRNB) Receives a Buy from H.C. Wainwright
04:13pm, Thursday, 06'th Feb 2020
In a report released today, Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Principia Biopharma (PRNB – Research
Sanofi BTK inhibitor successful in mid-stage MS study; shares up 3% premarket
11:58am, Thursday, 06'th Feb 2020
Sanofi (NASDAQ:SNY) perks up 3% premarket on light volume in reaction to positive results from a Phase 2b clinical trial evaluating SAR442168 in patients with relapsing multiple sclerosis (MS)
Principia Biopharma Inc (NASDAQ:PRNB) Receives Average Rating of "Buy" from Analysts
09:04am, Thursday, 06'th Feb 2020
Shares of Principia Biopharma Inc (NASDAQ:PRNB) have been given a consensus rating of “Buy” by the six research firms that are covering the stock, MarketBeat Ratings reports. One research analyst
Biotechs Feel The Bern
02:30pm, Monday, 03'rd Feb 2020
Healthcare is entering a period where election cycle impact will grow. The Medicare for All healthcare plan will begin to get factored based on the success of t
Tapping the Brakes on Tesla
01:00am, Saturday, 01'st Feb 2020
Also, analysts’ opinions on New york Community Bancorp, Imax, Principia Biopharma, and Dolby Labs.
Tonix Pharmaceuticals Moves Ahead, And Other News: The Good, Bad, And Ugly Of Biopharma
08:39pm, Thursday, 30'th Jan 2020
Tonix Pharmaceuticals moves ahead with TNX 102 SL. TrovaGene jumps on data. Principia gets bearish coverage.
Principia Biopharma (NASDAQ:PRNB) Earns "Buy" Rating from HC Wainwright
07:12am, Wednesday, 29'th Jan 2020
Principia Biopharma (NASDAQ:PRNB)‘s stock had its “buy” rating reaffirmed by equities researchers at HC Wainwright in a note issued to investors on Tuesday, TipRanks reports. They presently have
